Treatment of skin aging with topical estrogens

International Journal of Dermatology

Volumn 35, Issue 9, 1996, Pages 669-674

  Schmidt, Jolanta B ^a   Binder, Martina ^b   Demschik, Gabriele ^b   Bieglmayer, Christian ^b   Reiner, Angelika ^b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PIGMENT DISORDER; SKIN DISEASE; SKIN WATER LOSS; TOPICAL DRUG ADMINISTRATION;

EID: 0029821818     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb03701.x     Document Type: Article

References (30)

1. Kligman AM, Grove GL, Hirose R, Leyden J. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15:836-859.
2. Weiss JW, Ellis CN, Headington JT, Vorhees JJ. Topical tretinoin in the treatment of aging skin. J Am Acad Dermatol 1988; 19:169-175.
3. Tong PHS, Horowitz MS, Wheller LA. Transretinoic acid enhances the growth responses of epidermal keratinocytes to epidermal growth factor and transforming growth factor beta. J Invest Dermatol 1990; 87:663-667.
4. Harper RA, Burgoon T. Differential effects of retinoic acid on the growth of normal fibroblast-like cells in vitro from human, swine and rabbit skin. Cell Biol Int Rep 1982; 6:163-170.
5. Kligman LH, Kligman AM. Skin changes in photoaging: characteristics, prevention and repair. In: Balin AK, Kligman AM, eds. Aging and the skin. New York: Raven Press, 1989:331-346.
6. Artner J, Gitsch E. Über Lokalwirkungen von Östriol. Geburtshilfe und Frauenheilkd 1959; 19:812-819.
7. Boselli F, Volpe A, Genazzani AR. Topical therapy: estriol vaginal cream in postmenopausal women. In: Genazzani AR, Volpe A, Facchinetti F, eds. Gynaecological endocrinology. Carnforth: Parthenon Publishing, 687-694.
8. Riedel M, Raffenbeul W, Lichtlen P. Ovarian sex steroids and atherosclerosis. Clin Invest 1993; 71: 406-412.
9. Falkeborn M, Persson I, Adami HO, et al. The risk of acute myocardial infarction after oestrogen and oestrogen and progestogen replacement. Br J Obstet Gynecol 1992; 99:821-828.
10. Gallagher JC, Nordin BEC. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women. In: Frontiers of Hormone Research 3. Basel: Karger :150-176.
11. Schmidt JB, Spona J. Östrogen- und Androgenrezeptoren bei Patienten mit Akne vulgaris. Arch Dermatol Res 1980; 268:207-215.
12. Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30:97-100.
13. Punnonen R, Vaajalahti P, Teisala K. Local oestriol treatment improves the structure of elastic fibres in the skin of postmenopausal women. Ann Chir Gynaecol (Suppl) 1987; 202:39-41.
14. Grosman N, Hridbey E, Schon J. The effect of oestrogenic treatment on the acid mucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol 1971; 30:458-464.
15. Grosman N. Studies on the hyaluronic acid protein complex the molecular size of hyaluronic acid and the exchangeability of chloride in skin of mice before and after oestrogen treatment. Acta Pharmacol Toxicol 1973; 33:201-208.
16. Luisi M, Franchi F, Kicovic PM. A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy. Maturitas 1980; 2:311-319.
17. Schmidt JB, Binder M, Macheiner W, et al. Treatment of skin aging symptoms in perimenopausal females with estrogen compounds - a pilot study. Maturitas 1994; 20:25-30.
18. Schmidt JB, Binder M, Macheiner W, Bieglmayer CH. New treatment of atrophic acne-scars by iontophoresis with estriol and tretinoin - a pilot study. Int J Dermatol 1995; 34:53-57.
19. Reinthaller A, Kirchheimer JC, Deutinger J, et al. Plasminogen activators, plasminogen activator inhibitor and fibronectin in human granulosa cells and follicular fluid related to oocyte maturation and intrafollkular gonadotropin levels. Fertil Steril 1990; 54:1045-1051.
20. Binder M, Macheiner W, Schmidt JB. Die Profilometrie - eine Dokumentationsmethode der Hautstruktur. Hautarzt 1994; 45:546-550.
21. Schmidt JB, Hobisch G, Lindmaier A. Epidermal moisture and skin surface lipids throughout life as parameters for cosmetic care. Appl Cosmetol 1990; 8:17-22.
22. Kainz C, Gitsch G, Stani J, et al. When applied to facial skin, does estrogen ointment have systemic effects? Arch Gynecol Obstet 1993; 253:71-74.
23. Lauritzen C. Erfahrungen mit einer Östriol-Vaginalcreme. Therapie Gegenw 1979; 118:567-577.
24. Tzingouinis VA, Aksu MF, Greenblatt RB. The significance of oestriol in the management of the post menopause. Acta Endocrinol Suppl 1980; 233:45-50.
25. Frost P, Weinstein GD, Hsia SL. Metabolism of oestradiol and oestrogen in human skin. J Invest Dermatol 1966; 46:584-585.
26. Wendker H, Schaefer H, Zesch A. Penetrationskinetik und Verteilung lokal applizierter Östrogene. Arch Dermatol Res 1976; 256:67-74.
27. Epstein EH, Munderloh NH. Isolation and characterization of CNBr peptides of human (alpha I [III] 3) collagen and tissue distribution of (alpha 1 [I] 2), alpha 2 and (alpha 1 [III] 3) collagens. J Biol Chem 1975; 250: 9304-9312.
28. Epstein EH. (Alpha 1 [3]) human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem 1974; 249:3225-3231.
29. Rauramo L, Punnonen R. Wirkungen von Kastration und Östrogentherapie auf die Haut er Frau. Therap Umschau 1974; 31:173-175.
30. Brincat M, Moniz CJ, Studd JW. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92:256-259.